← brief for 2026-09-17 · Slowing decline

Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis

Article C Peer reviewed Observational

Key takeaways

This study looked at safety reports for three cancer drugs. It found that each drug has a different pattern of kidney side effects. This shows a link between the drugs and kidney issues, but it is not proof of cause.

Who did this work

Suleyman Sami Guzel (Istanbul University-Cerrahpaşa) · Aydan Mutis Alan (Karen Hospital) · Kubilay Tay (Istanbul University-Cerrahpaşa) · Nebi Serkan Demirci (Istanbul University-Cerrahpaşa) · Ozkan Alan (Istanbul University-Cerrahpaşa)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-17
https://doi.org/10.3389/fphar.2026.1917719